| | |
| 0343 |
8:00 AM | Periodontal Treatment by Minocycline Microspheres in Type 1 Diabetes Patients
U. SKALERIC1, R. SCHARA1, M. MEDVESCEK1, A. HANLON2, F. DOHERTY2, and J. LESSEM2, 1Center of Dental Research, Ljubljana, Slovenia, 2OraPharma Inc, Warminster, PA, USA |
| 0344 |
8:15 AM | A Pilot Study: Efficacy of Minocycline Microspheres in Type-1 Diabetics
F. DOHERTY1, U. SKALERIC2, R. SCHARA2, M. MEDVESCEK2, A. HANLON1, and J. LESSEM1, 1Orapharma Inc, Warminster, PA, USA, 2University of Ljubljana, Slovenia |
| 0345 |
8:30 AM | Initial Periodontal Therapy: Systemic and/or Locally-delivered Antibiotics as Adjuncts
J.M. GOODSON1, A. HAFFAJEE1, J. WENNSTROM2, J. LINDHE3, A. BOGREN2, T. VAN DYKE4, H. HASTURK4, R. KENT1, and S. SOCRANSKY1, 1Forsyth Institute, Boston, MA, USA, 2University of Goteborg, Sweden, 3University of Goteborg, Gothenburg, Sweden, 4Boston University, MA, USA |
| 0346 |
8:45 AM | Duration of Effect After Periodontal Pocket Treatment With Subgingival Doxycycline
A.M. POLSON1, A.P. POLSON1, L. SOUTHARD2, R. DUNN2, G. YEWEY2, K. GODOWSKI2, J. FULFS3, R. ASHLEY4, and L. LASTER1, 1University of Pennsylvania, Philadelphia, USA, 2Atrix Labs, Ft Collins, USA, 3Inhausen Research Inst, Ft Collins, USA, 4Collagenex, Newtown, USA |
| 0347 |
9:00 AM | Effect of initial periodontal therapy on proinflammatory cytokines in GCF
E. BLACK1, L. YU1, H. HASTURK1, M. WARBINGTON1, D. GUERRERO2, A. KANTARCI1, J. GOODSON3, and T.E. VAN DYKE1, 1Boston University, MA, USA, 2Forsyth Institute, Boston, MA, USA, 3The Forsyth Institute, Boston, MA, USA |
| 0348 |
9:15 AM | Growth factors and Cytokines Enhance Fluoroquinolone Accumulation by Gingival Fibroblasts
S.Y. RAWAL1, R.J. NAKKULA2, and J.D. WALTERS2, 1Ohio State University, College of Dentistry, Columbus, USA, 2Ohio State University, College of Dentistry, Columbus, ND, USA |
|